Long-term results of phase II trial of apatinib for progressive radioiodine refractory differentiated thyroid cancer
Journal of Clinical Endocrinology and Metabolism | Apr 01, 2021
Most read this week
Journal of Clinical Endocrinology and Metabolism | Apr 01, 2021